Results 241 to 250 of about 28,557 (262)

Serum HE4 as a prognostic marker in endometrial cancer — A population based study

Gynecologic Oncology, 2014
Donal Brennan, Jermaine I Coward, Michael A Quinn   +2 more
exaly  

Serum levels of the ovarian cancer biomarker HE4 are decreased in pregnancy and increase with age

American Journal of Obstetrics and Gynecology, 2012
Richard G Moore, Robert C Bast
exaly  

HE4 is an independent prognostic marker in endometrial cancer patients

Gynecologic Oncology, 2012
Heidelinde Fiegl, Christian Marth
exaly  

Increased levels of HE4 (WFDC2) in systemic sclerosis: a novel biomarker reflecting interstitial lung disease severity?

Therapeutic Advances in Chronic Disease, 2020
Mingxia Zhang
exaly  

The role of novel biomarker HE4 in endometrial cancer: a case control prospective study

Tumor Biology, 2012
Roberto Ra Angioli, Francesco Plotti, Stella Capriglione   +2 more
exaly  

Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer

Gynecologic Oncology, 2010
M Robyn Andersen, Nathalie Scholler
exaly  

Role of HE4, CA72.4, and CA125 in monitoring ovarian cancer

Tumor Biology, 2012
Luigi Frati, Emanuela Anastasi
exaly  

Prognostic significance of HE4 expression in pulmonary adenocarcinoma

Tumor Biology, 2010
Shin-Ichi Yamashita
exaly  

Diagnostic performance of the biomarkers HE4 and CA125 in type I and type II epithelial ovarian cancer

Gynecologic Oncology, 2013
Kristina Levan, Karin Sundfeldt
exaly  

Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients

British Journal of Cancer, 2011
Stefano Calza, Chiara Romani, Franco E Odicino   +2 more
exaly